Lauren Harshman
Medical Oncology · Boston, MANPI 1689856684
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (46.7%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 6 manufacturers reported payments, led by Exelixis Inc. at 40.3% of the total.
Across 25 payments — averaging $1009.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Exelixis Inc.$10K
- Merck$5K
- Advanced Accelerator Applications$5K
- Pfizer$2K
- F. Hoffmann-la Roche AG$2K
- E.r. Squibb & Sons, L.L.C.$1K
Across 49 payments — averaging $34,355 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Merck$753K
- Bayer$511K
- Takeda Pharmaceuticals U.S.A., Inc.$219K
- Pfizer$118K
- Janssen Research & Development, LLC$60K
- Genentech, Inc.$18K
- plus $4K from 2 others
What the payments were for
- Consulting fees$11,78847%
- Speaking & faculty fees$9,24037%
- Travel & lodging$3,14812%
- Food & beverage$1,0584%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Exelixis Inc. | 7 | $10,168 |
| Merck | 4 | $5,126 |
| Advanced Accelerator Applications | 3 | $4,961 |
| Pfizer | 4 | $2,184 |
| F. Hoffmann-la Roche AG | 5 | $1,565 |
| E.r. Squibb & Sons, L.L.C. | 2 | $1,230 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Cabometyx$9,948
- BAVENCIO$1,888
- Non-Covered Product$1,533
- OPDIVO$1,230
- INLYTA$161
How this compares
$25,234 in reported general payments places this provider in the 70th percentile of 308 medical oncology providers in Massachusetts.
Other medical oncology in Boston
- George DemetriBoston$1.6M
- Keith FlahertyBoston$932K
- Alicia MorgansBoston$690K
- Pasi Antero JanneBoston$458K
- Robert HaddadBoston$451K
- Irene GhobrialBoston$431K
- Joaquin Bellmunt MolinsBoston$415K
- Jeremy AbramsonBoston$334K
- Justin GainorBoston$324K
- Narjust FlorezBoston$324K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.